EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune Regulation by Regnase‐1 and Related Endoribonucleases

Takuya Uehata, Osamu Takeuchi

European Journal of Immunology · 2026-11 · 56 (11)

DOI: 10.1002/eji.70313 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 04.11.2026. Verfasst von Takuya Uehata und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Ribonucleases, Endoribonucleases. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AMED, Japan Society for the Promotion of Science, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regnase‐1 (ZC3H12A) is a stem‐loop (SL)‐recognizing endoribonuclease that couples immune stimulation to selective mRNA decay. Although originally characterized as a negative regulator of inflammatory cytokine expression, recent studies have expanded this view by placing Regnase‐1 within a broader network of SL‐recognizing RNA decay factors, including Roquin proteins and Regnase‐3, and by revealing context‐dependent functions in immune and nonimmune cells. Through regulation of transcripts encoding cytokines, costimulatory molecules, and transcriptional regulators, Regnase‐1 restrains innate and adaptive immune activation, but biological output varies according to cell type, tissue environment, disease stage, and mode of perturbation. In T cells, including engineered T cells used in adoptive cell therapy, Regnase‐1 inhibition can enhance antitumor activity in preclinical models, whereas in epithelial tissues Regnase‐1 can limit inflammatory circuits that affect host defense, tissue injury, and inflammation‐associated tumorigenesis. Structure‐targeting antisense oligonucleotides and genome‐editing approaches have further raised the possibility of therapeutically modulating Regnase‐dependent RNA decay. In this Review, we discuss molecular mechanisms of Regnase‐1‐mediated mRNA decay, context‐dependent functions across tissues and diseases, and the opportunities and limitations of targeting this pathway therapeutically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RibonucleasesEndoribonucleasesHumansAnimalsRNA StabilityT-LymphocytesAdaptive ImmunityImmunity, InnateInflammationTranscription Factors

Stichwörter der Autor:innen

RNA binding proteinsantisense oligonucleotidesmRNA decaystem‐loop structures

Substanzen

RibonucleasesZC3H12A protein, humanEndoribonucleasesTranscription Factors

Autor:innen und Institutionen

  • Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Förderung

  • AMED
  • Japan Society for the Promotion of Science
  • Takeda Science Foundation
  • TERUMO LIFE SCIENCE FOUNDATION
  • Japan Agency for Medical Research and Development

Zitieren

APA

Uehata, T., & Takeuchi, O. (2026). Immune Regulation by Regnase‐1 and Related Endoribonucleases. European Journal of Immunology, 56(11). https://doi.org/10.1002/eji.70313

Vancouver

Uehata T, Takeuchi O. Immune Regulation by Regnase‐1 and Related Endoribonucleases. European Journal of Immunology. 2026;56(11). doi:10.1002/eji.70313

BibTeX
@article{Uehata2026,
  author = {Uehata, Takuya and Takeuchi, Osamu},
  title = {Immune Regulation by Regnase‐1 and Related Endoribonucleases},
  journal = {European Journal of Immunology},
  year = {2026},
  volume = {56},
  number = {11},
  doi = {10.1002/eji.70313}
}
Kostenlos starten →